These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36429011)

  • 1. A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist.
    Papaccio F; Bellei B; Ottaviani M; D'Arino A; Truglio M; Caputo S; Cigliana G; Sciuto L; Migliano E; Pacifico A; Iacovelli P; Picardo M
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of PPAR-γ agonist pioglitazone on the prolifeiration of malignant nesothelionma cells induced by HMGB1].
    Wang YB; Shen W; Gan YH; Zou J; Zhang Y; Zhu LJ; Ju L; Jiang ZQ; Ying SB
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Sep; 39(9):641-647. PubMed ID: 34624942
    [No Abstract]   [Full Text] [Related]  

  • 3. PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling via RGS4 Signaling in Mouse Model.
    Meng X; Sun X; Zhang Y; Shi H; Deng W; Liu Y; Wang G; Fang P; Yang S
    Inflammation; 2018 Dec; 41(6):2079-2089. PubMed ID: 30022363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.
    Ito Y; Yamamoto M; Furukawa S; Fukui M; Morishita K; Kitao T; Shirahase H
    Biol Pharm Bull; 2021; 44(5):659-668. PubMed ID: 33952822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis.
    Aoki Y; Maeno T; Aoyagi K; Ueno M; Aoki F; Aoki N; Nakagawa J; Sando Y; Shimizu Y; Suga T; Arai M; Kurabayashi M
    Respiration; 2009; 77(3):311-9. PubMed ID: 18974632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ activation by pioglitazone enhances the anti-proliferative effects of doxorubicin on pro-monocytic THP-1 leukemia cells via inducing apoptosis and G2/M cell cycle arrest.
    Ghasemi H; Jamshidi A; Ghatee MA; Mazhab-Jafari K; Khorasani M; Rahmati M; Mohammadi S
    J Recept Signal Transduct Res; 2022 Oct; 42(5):429-438. PubMed ID: 34645362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
    Chen Z; Yuan P; Sun X; Tang K; Liu H; Han S; Ye T; Liu X; Yang X; Zeng J; Yan L; Xing J; Xiao K; Ye Z; Xu H
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F137-F151. PubMed ID: 31091119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.
    Li MY; Kong AW; Yuan H; Ma LT; Hsin MK; Wan IY; Underwood MJ; Chen GG
    Curr Cancer Drug Targets; 2012 Jul; 12(6):597-606. PubMed ID: 22463586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells.
    Mollo N; Nitti M; Zerillo L; Faicchia D; Micillo T; Accarino R; Secondo A; Petrozziello T; Calì G; Cicatiello R; Bonfiglio F; Sarnataro V; Genesio R; Izzo A; Pinton P; Matarese G; Paladino S; Conti A; Nitsch L
    Front Genet; 2019; 10():606. PubMed ID: 31316549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain.
    García-Ruiz I; Solís-Muñoz P; Fernández-Moreira D; Muñoz-Yagüe T; Solís-Herruzo JA
    BMC Biol; 2013 Aug; 11():88. PubMed ID: 23915000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.
    Lin X; Meng X; Song Z; Lin J
    Mol Cell Biochem; 2022 Jul; 477(7):1905-1920. PubMed ID: 35348980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Skin Permeation Studies with PPARγ Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes.
    Silva-Abreu M; Espinoza LC; Rodríguez-Lagunas MJ; Fábrega MJ; Espina M; García ML; Calpena AC
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29182532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo.
    Willemsen M; Krebbers G; Tjin EPM; Willemsen KJ; Louis A; Konijn VAL; Narayan VS; Post NF; Bakker WJ; Melief CJM; Bekkenk MW; Luiten RM
    Exp Dermatol; 2022 Apr; 31(4):556-566. PubMed ID: 34758170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV inhibitor lowers PPARγ agonist-induced body weight gain by affecting food intake, fat mass, and beige/brown fat but not fluid retention.
    Masuda T; Fu Y; Eguchi A; Czogalla J; Rose MA; Kuczkowski A; Gerasimova M; Feldstein AE; Scadeng M; Vallon V
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E388-98. PubMed ID: 24347054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.
    Da Silva Morais A; Abarca-Quinones J; Horsmans Y; Stärkel P; Leclercq IA
    Int J Mol Med; 2007 Jan; 19(1):105-12. PubMed ID: 17143554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia.
    Izawa Y; Takahashi S; Suzuki N
    Brain Res; 2009 Dec; 1305():64-73. PubMed ID: 19800324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype.
    Mori D; Miyagawa S; Matsuura R; Sougawa N; Fukushima S; Ueno T; Toda K; Kuratani T; Tomita K; Maeda N; Shimomura I; Sawa Y
    Cardiovasc Diabetol; 2019 Mar; 18(1):39. PubMed ID: 30902059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin.
    Dell'Anna ML; Ottaviani M; Kovacs D; Mirabilii S; Brown DA; Cota C; Migliano E; Bastonini E; Bellei B; Cardinali G; Ricciardi MR; Tafuri A; Picardo M
    Sci Rep; 2017 Oct; 7(1):13663. PubMed ID: 29057950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress.
    Kang P; Zhang W; Chen X; Yi X; Song P; Chang Y; Zhang S; Gao T; Li C; Li S
    Free Radic Biol Med; 2018 Oct; 126():259-268. PubMed ID: 30138713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.